Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant.

Keyword

Acromegaly/*blood/*drug therapy/etiology

Adenoma/complications/pathology

Adolescent

Adult

Area Under Curve

Blood Glucose/metabolism

Delayed-Action Preparations

Female

Glucose/*metabolism

Glucose Tolerance Test

Hemoglobin A; Glycosylated/metabolism

Homeostasis/*drug effects

Human Growth Hormone/administration & dosage/adverse effects/*analogs & derivatives/blood/therapeutic use

Humans

Insulin/blood

Insulin-Like Growth Factor I/metabolism

Male

Middle Aged

Octreotide/administration & dosage/*adverse effects/*therapeutic use

Pituitary Neoplasms/complications

Publication and Content Type

ref (subject category)

art (subject category)